TY - JOUR
T1 - The structure of the dichromium compound Cr2(μ-OH)2 (μ-3,5Cl2-form)2 (η2-3,5Cl2-form)2
AU - Donahue, Carolyn G.
AU - Carruthers, Vern B.
AU - Gilk, Stacey D.
AU - Ward, Gary E.
N1 - Funding Information:
Authors L. Smith, K. Carlson-Day, and J. Eglin would like to acknowledge the NSF EPSCoR program Grant # EHR 9108767. X-ray diffraction studies were supported by NSF Instrumentation Grant # NSF-9528493.
PY - 2000/12/15
Y1 - 2000/12/15
N2 - With exposure to trace amounts of air and moisture, the Cr2(II, II) complex Cr2(μ-3,5Cl2-form)4, where 3,5Cl2-form is [(3,5-Cl2C6H3) NC(H)N(3,5-Cl2C6H3)-], undergoes an oxidative addition reaction. Structural information from the X-ray crystal structure of the edge-sharing bioctahedral (ESBO) Cr2(III, III) product Cr2(μ-OH)2 (μ-3,5Cl2-form)2(η2 -3,5Cl2-form)2 (1) indicates 1 has a significantly longer Cr-Cr distance [2.732(2) Å] than Cr2(μ-3,5Cl2-form)4 [1.9162(10) Å], but the shortest Cr-Cr distance in an ESBO Cr2(III, III) complex recorded to date.
AB - With exposure to trace amounts of air and moisture, the Cr2(II, II) complex Cr2(μ-3,5Cl2-form)4, where 3,5Cl2-form is [(3,5-Cl2C6H3) NC(H)N(3,5-Cl2C6H3)-], undergoes an oxidative addition reaction. Structural information from the X-ray crystal structure of the edge-sharing bioctahedral (ESBO) Cr2(III, III) product Cr2(μ-OH)2 (μ-3,5Cl2-form)2(η2 -3,5Cl2-form)2 (1) indicates 1 has a significantly longer Cr-Cr distance [2.732(2) Å] than Cr2(μ-3,5Cl2-form)4 [1.9162(10) Å], but the shortest Cr-Cr distance in an ESBO Cr2(III, III) complex recorded to date.
KW - Cr(II, II) complexes
KW - Cr(III, III) complexes
KW - Dichromium compound
KW - X-ray crystal structures
UR - http://www.scopus.com/inward/record.url?scp=0034671144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034671144&partnerID=8YFLogxK
U2 - 10.1016/S0020-1693(00)00289-9
DO - 10.1016/S0020-1693(00)00289-9
M3 - Article
AN - SCOPUS:0034671144
SN - 0020-1693
VL - 310
SP - 282
EP - 284
JO - Inorganica Chimica Acta
JF - Inorganica Chimica Acta
IS - 2
ER -